These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37891847)

  • 21. HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History.
    Illenberger JM; Harrod SB; Mactutus CF; McLaurin KA; Kallianpur A; Booze RM
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):715-728. PubMed ID: 32533296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.
    Purohit V; Rapaka R; Shurtleff D
    Mol Neurobiol; 2011 Aug; 44(1):102-10. PubMed ID: 21717292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.
    Kesby JP; Markou A; Semenova S;
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):141-50. PubMed ID: 25476577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.
    Ghura S; Gross R; Jordan-Sciutto K; Dubroff J; Schnoll R; Collman RG; Ashare RL
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):694-714. PubMed ID: 31834620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geriatric Syndromes in People Living with HIV Associated with Ageing and Increasing Comorbidities: Implications for Neurocognitive Complications of HIV Infection.
    Falutz J; Kirkland S; Guaraldi G
    Curr Top Behav Neurosci; 2021; 50():301-327. PubMed ID: 31907879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV, Vascular Risk Factors, and Cognition in the Combination Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis.
    McIntosh EC; Tureson K; Rotblatt LJ; Singer EJ; Thames AD
    J Int Neuropsychol Soc; 2021 Apr; 27(4):365-381. PubMed ID: 33161930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral Evidence for a Tau and HIV-gp120 Interaction.
    Vijayan M; Yin L; Reddy PH; Benamar K
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions.
    Namba MD; Xie Q; Barker JM
    Brain Behav Immun; 2023 Oct; 113():453-475. PubMed ID: 37567486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study.
    Alford K; Daley S; Banerjee S; Vera JH
    PLoS One; 2021; 16(5):e0251944. PubMed ID: 34010362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice.
    Mediouni S; Jablonski J; Paris JJ; Clementz MA; Thenin-Houssier S; McLaughlin JP; Valente ST
    Curr HIV Res; 2015; 13(1):64-79. PubMed ID: 25613133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.
    Marquine MJ; Iudicello JE; Morgan EE; Brown GG; Letendre SL; Ellis RJ; Deutsch R; Woods SP; Grant I; Heaton RK;
    Psychiatry Res; 2014 Jan; 215(1):208-16. PubMed ID: 24290100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV.
    Pasipanodya EC; Kohli M; Fisher CB; Moore DJ; Curtis B
    Harm Reduct J; 2020 Jun; 17(1):41. PubMed ID: 32527276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
    Teodorof-Diedrich C; Spector SA
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30158296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial.
    Goodman-Meza D; Shoptaw S; Weiss RE; Nakazono T; Harawa NT; Takada S; Garland WH; Cunningham WE
    Drug Alcohol Depend; 2019 Sep; 202():178-184. PubMed ID: 31352308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine.
    Nair MP; Samikkannu T
    Curr HIV Res; 2012 Jul; 10(5):429-34. PubMed ID: 22591367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV.
    LaRowe LR; Cleveland JD; Long DM; Nahvi S; Cachay ER; Christopoulos KA; Crane HM; Cropsey K; Napravnik S; O'Cleirigh C; Merlin JS; Ditre JW
    AIDS Care; 2021 Dec; 33(12):1534-1542. PubMed ID: 33594924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.
    Mediouni S; Marcondes MC; Miller C; McLaughlin JP; Valente ST
    Front Microbiol; 2015; 6():1164. PubMed ID: 26557111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders.
    Bryant VE; Whitehead NE; Burrell LE; Dotson VM; Cook RL; Malloy P; Devlin K; Cohen RA
    AIDS Behav; 2015 Aug; 19(8):1430-7. PubMed ID: 25533921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.
    Wayman WN; Chen L; Persons AL; Napier TC
    Curr HIV Res; 2015; 13(1):80-7. PubMed ID: 25760043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
    Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A
    Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.